Curium Announces FDA Approval of a Generic Version of DaTsca

ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug Administration

Related Keywords

United States , American , Ted Porter , Kostenloser Wertpapierhandel , Sandy Borgschulte , Michael Patterson , Datscan Ioflupane , Pierre Curie , Drug Administration , Ge Healthcare , Parkinsonian Syndromes , North American , North American Vice President , Hepatic Impairment , Prescribing Information , Accurium , Nnounces , Approval , Generic , Version , Datscan , Oflupane , Injection ,